Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 23681072)

1.

Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma.

Takeuchi T, Ohishi Y, Imamura H, Aman M, Shida K, Kobayashi H, Kato K, Oda Y.

Am J Surg Pathol. 2013 Jul;37(7):1091-9. doi: 10.1097/PAS.0b013e3182834d41.

PMID:
23681072
2.

Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.

Ali RH, Seidman JD, Luk M, Kalloger S, Gilks CB.

Int J Gynecol Pathol. 2012 Nov;31(6):499-506. doi: 10.1097/PGP.0b013e31824d7445.

PMID:
23018212
3.
4.

Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.

Cuatrecasas M, Catasus L, Palacios J, Prat J.

Am J Surg Pathol. 2009 Apr;33(4):556-67. doi: 10.1097/PAS.0b013e318188b84c.

PMID:
19033864
5.

Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.

Madore J, Ren F, Filali-Mouhim A, Sanchez L, Köbel M, Tonin PN, Huntsman D, Provencher DM, Mes-Masson AM.

J Pathol. 2010 Feb;220(3):392-400. doi: 10.1002/path.2659.

PMID:
19967725
6.

Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma.

Karnezis AN, Aysal A, Zaloudek CJ, Rabban JT.

Am J Surg Pathol. 2013 Jan;37(1):24-37. doi: 10.1097/PAS.0b013e31826a5399.

PMID:
23108017
7.
8.

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.

Am J Surg Pathol. 2009 Oct;33(10):1504-14. doi: 10.1097/PAS.0b013e3181ac35f5.

PMID:
19623034
10.

Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.

Mansor S, McCluggage WG.

Int J Gynecol Pathol. 2014 Sep;33(5):470-6. doi: 10.1097/PGP.0000000000000087.

PMID:
25083962
11.
12.

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.

Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IeM, Kurman RJ.

Mod Pathol. 2011 Sep;24(9):1248-53. doi: 10.1038/modpathol.2011.85. Epub 2011 May 6.

13.

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

McCluggage WG.

Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Review.

PMID:
21716157
14.

p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.

Liao XY, Xue WC, Shen DH, Ngan HY, Siu MK, Cheung AN.

Histopathology. 2007 Oct;51(4):477-83.

PMID:
17880529
15.

[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].

Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.

Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Chinese.

PMID:
17631760
16.

High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.

Alkushi A, Köbel M, Kalloger SE, Gilks CB.

Int J Gynecol Pathol. 2010 Jul;29(4):343-50. doi: 10.1097/PGP.0b013e3181cd6552.

PMID:
20567148
17.

Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.

Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM.

Int J Gynecol Pathol. 2012 Jul;31(4):297-303. doi: 10.1097/PGP.0b013e31823f8482.

18.

IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.

Zhang L, Liu Y, Hao S, Woda BA, Lu D.

Am J Surg Pathol. 2011 Jun;35(6):868-72. doi: 10.1097/PAS.0b013e318219c6f9.

PMID:
21566514
19.

Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.

Karamurzin Y, Leitao MM Jr, Soslow RA.

Am J Surg Pathol. 2013 Mar;37(3):356-67. doi: 10.1097/PAS.0b013e318272ff19.

PMID:
23282975
20.

Molecular characterization of 103 ovarian serous and mucinous tumors.

Vereczkey I, Serester O, Dobos J, Gallai M, Szakács O, Szentirmay Z, Tóth E.

Pathol Oncol Res. 2011 Sep;17(3):551-9. doi: 10.1007/s12253-010-9345-8. Epub 2010 Dec 7.

PMID:
21136228
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk